IRF4 haploinsufficiency in a family with Whipple's disease
- INSERM U1163, France
- Sidra Medical and Research Center, Qatar
- The Rockefeller University, United States
- University Aix-Marseille (URMITE), France
- Garvan Institute of Medical Research, Australia
- Memorial Sloan Kettering Cancer Center, United States
- Institut Pasteur, France
- Cochin Hospital, France
- Imagine Institute, Paris Descartes University, France
Abstract
Most humans are exposed to Tropheryma whipplei (Tw). Whipple's disease (WD) strikes only a small minority of individuals infected with Tw (<0.01%), whereas asymptomatic chronic carriage is more common (<25%). We studied a multiplex kindred, containing four WD patients and five healthy Tw chronic carriers. We hypothesized that WD displays autosomal dominant (AD) inheritance, with age-dependent incomplete penetrance. We identified a single very rare non-synonymous mutation in the four patients: the private R98W variant of IRF4, a transcription factor involved in immunity. The five Tw carriers were younger, and also heterozygous for R98W. We found that R98W was loss-of-function, modified the transcriptome of heterozygous leukocytes following Tw stimulation, and was not dominant-negative. We also found that only six of the other 153 known non-synonymous IRF4 variants were loss-of-function. Finally, we found that IRF4 had evolved under purifying selection. AD IRF4 deficiency can underlie WD by haploinsufficiency, with age-dependent incomplete penetrance.
Data availability
-
IRF4 haplo-insufficiency underlies a familial form of Whipple's diseasePublicly available at the NCBI Gene Expression Omnibus (accession no: GSE102862).
Article and author information
Author details
Jean-Laurent Casanova
Funding
Centre National de la Recherche Scientifique
- Lluis Quintana-Murci
Agence Nationale de la Recherche (ANR-14-CE14-0008-02)
- Lluis Quintana-Murci
Agence Nationale de la Recherche (ANR-14-CE14-0007-02)
- Lluis Quintana-Murci
H2020 European Research Council
- Lluis Quintana-Murci
National Health and Medical Research Council (1113904)
- Stuart G Tangye
University of New South Wales
- Lisa Worley
- Tina Nguyen
Agence Nationale de la Recherche (ANR-16-CE17-0005-01)
- Antoine Guérin
National Institutes of Health (5R01AI089970-02)
- Jean-Laurent Casanova
National Health and Medical Research Council (1042925)
- Cindy S Ma
Office of Health and Medical Research
- Cindy S Ma
- Stuart G Tangye
H2020 European Research Council (281297)
- Lluis Quintana-Murci
- Jean-Laurent Casanova
Seventh Framework Programme (FP/2007-2013)
- Lluis Quintana-Murci
Agence Nationale de la Recherche (ANR-IFNPHOX (ANR-13-ISV3-001-01))
- Jacinta Bustamante
Agence Nationale de la Recherche (ANR-10-LABX-62-IBEID)
- Lluis Quintana-Murci
- Laurent Abel
- Jean-Laurent Casanova
Agence Nationale de la Recherche (ANR-GENMSMD (ANR-16-CE17-0005-01))
- Jacinta Bustamante
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: Informed consent was obtained from all family members, and the study was approved by the national ethics committee.
Copyright
© 2018, Guérin et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,075
- views
-
- 521
- downloads
-
- 51
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
IRF4 haploinsufficiency in a family with Whipple's disease
eLife 7:e32340.
https://doi.org/10.7554/eLife.32340
Further reading
-
- Immunology and Inflammation
- Medicine
Preeclampsia (PE), a major cause of maternal and perinatal mortality with highly heterogeneous causes and symptoms, is usually complicated by gestational diabetes mellitus (GDM). However, a comprehensive understanding of the immune microenvironment in the placenta of PE and the differences between PE and GDM is still lacking. In this study, cytometry by time of flight indicated that the frequencies of memory-like Th17 cells (CD45RA−CCR7+IL-17A+CD4+), memory-like CD8+ T cells (CD38+CXCR3−CCR7+Helios−CD127−CD8+) and pro-inflam Macs (CD206−CD163−CD38midCD107alowCD86midHLA-DRmidCD14+) were increased, while the frequencies of anti-inflam Macs (CD206+CD163−CD86midCD33+HLA-DR+CD14+) and granulocyte myeloid-derived suppressor cells (gMDSCs, CD11b+CD15hiHLA-DRlow) were decreased in the placenta of PE compared with that of normal pregnancy (NP), but not in that of GDM or GDM&PE. The pro-inflam Macs were positively correlated with memory-like Th17 cells and memory-like CD8+ T cells but negatively correlated with gMDSCs. Single-cell RNA sequencing revealed that transferring the F4/80+CD206− pro-inflam Macs with a Folr2+Ccl7+Ccl8+C1qa+C1qb+C1qc+ phenotype from the uterus of PE mice to normal pregnant mice induced the production of memory-like IL-17a+Rora+Il1r1+TNF+Cxcr6+S100a4+CD44+ Th17 cells via IGF1–IGF1R, which contributed to the development and recurrence of PE. Pro-inflam Macs also induced the production of memory-like CD8+ T cells but inhibited the production of Ly6g+S100a8+S100a9+Retnlg+Wfdc21+ gMDSCs at the maternal–fetal interface, leading to PE-like symptoms in mice. In conclusion, this study revealed the PE-specific immune cell network, which was regulated by pro-inflam Macs, providing new ideas about the pathogenesis of PE.
-
- Immunology and Inflammation
Constitutive activation of STING by gain-of-function mutations triggers manifestation of the systemic autoinflammatory disease STING-associated vasculopathy with onset in infancy (SAVI). In order to investigate the role of signaling by tumor necrosis factor (TNF) in SAVI, we used genetic inactivation of TNF receptors 1 and 2 in murine SAVI, which is characterized by T cell lymphopenia, inflammatory lung disease and neurodegeneration. Genetic inactivation of TNFR1 and TNFR2, however, rescued the loss of thymocytes, reduced interstitial lung disease and neurodegeneration. Furthermore, genetic inactivation of TNFR1 and TNFR2 blunted transcription of cytokines, chemokines and adhesions proteins, which result from chronic STING activation in SAVI mice. In addition, increased transendothelial migration of neutrophils was ameliorated. Taken together, our results demonstrate a pivotal role of TNFR-signaling in the pathogenesis of SAVI in mice and suggest that available TNFR antagonists could ameliorate SAVI in patients.
